OTC Markets Group Welcomes CSL Limited (CSLLY) to OTCQX

OTC Markets Group Inc. (OTCMKTS:OTCM), operator of regulated markets for 12,000 U.S. and international securities, today announced CSL Limited (ASX:CSL) (OTCMKTS:CSLLY), a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology, has qualified to trade on the OTCQX(R) Best Market. CSL Limited upgraded to OTCQX from the Pink(R) market.

CSL Limited begins trading today on OTCQX under the symbol "CSLLY." U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.

Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their U.S. investors. For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home market reporting to make their information available in the U.S. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance and demonstrate compliance with applicable securities laws.

BNY Mellon acted as the company's OTCQX sponsor.

Media Contact: 
OTC Markets Group Inc.
T: +1 (212) 896-4428
E: media@otcmarkets.com

News Provided by ABN Newswire